The SGD Pharma group and its shareholder JIC

Announce an investment of more than 20 million euros to rebuild the furnace and modernize the century-old Sucy-en-Brie site  The Sucy-en-Brie factory, 400 employees, has been dedicated to producing pharmaceutical glass vials and bottles since 1917. The factory supplies syrups, droppers, tablets, injectable and infusion bottles to over 450 customers around the world and cover the following therapeutic areas: oral and parenteral antibiotics, parenteral nutrition, respiratory illness, pain-relievers, anesthetics, and OTC.

Every year, Sucy produces number of bottles of Type II & III flint and amber molded glass bottles, making this factory one of the biggest players in the European health care industry. Its 41,000 m² surface includes two furnaces, 8 production lines, connected to ISO 8 clean rooms. The factory operates under the most stringent quality requirements, and is certified ISO 15378 & 50001.

A major investment for the group The furnace renovation will include, complete rebuilt using the most advanced technologies available on the market to meet our continuous improvement initiatives while significantly reducing our environmental footprint. Benefits to our customers: a continued improvement in the quality of our products, an increased production flexibility, and a greater adaptation to market needs. This renovation, which will take a few weeks, has been planned for almost a year now which allowed us to optimize the stock management of critical items as well as establishing runs on the second furnace to ensure continuous supply. SGD Pharma continually strived to strengthen its operational excellence to provide quality products, reliable service to its customers and ensure patient safety.

 www.sgd-pharma.com

About SGD Pharma SGD Pharma has a unique know-how and offers innovative and premium quality glass packaging solutions consistent with international pharmacopoeias. SGD Pharma places the quality and safety of the patient at the center of its concerns. Our 5 manufacturing sites are totally dedicated to Pharmacy, certified ISO 15378. All our bottles are controlled and packaged in clean room ISO 8. SGD Pharma is implementing a quality policy both homogeneous and effective on all its sites of production, based on the respect of Good Manufacturing Practices. In the drug industry more than elsewhere, the security of the supply chain is a vital element. We carry out every effort to ensure a continuous supply and protect the client and patient. SGD Pharma provides back-up solutions between its different manufacturing sites for all types of glass. Our group’s mission, aligned with its DNA, is to improve and protect patient’s health by providing high quality, innovative and reliable primary glass packaging to our pharmaceutical customers.

I commenti sono chiusi.